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Colon cancer is the leading cause for the malignancy in the gastrointestinal tract. Autophagy is a self-degradation process of 
the unnecessary, injured and aged organelles and proteins in the cell, which is followed by recovering of degraded products. 
Apoptosis is a programmed cell death which is characterized by membrane blebbing, chromosome condensation and nuclear 
fragmentation. Apoptosis and autophagy can occur frequently in a cell, predominantly in a series preceding apoptosis through 
autophagy by the formation of autophagosomes. In current research, the impact of autophagy inhibition and apoptosis activation 
were found to be the targeted strategies to treat colon cancer. This study is focused on the apoptotic potential of RA-V, a natural 
cyclopeptide through the inhibition of protective autophagy in colon cancer cells. Growth inhibitory properties were observed in 
the RA-V treated (125 μM) colo 320DM cells using cell viability assay. RA-V induced apoptosis of colo 320DM cells at the 
maximum concentration of 125 μM, which was observed using DAPI and Annexin - PI staining methods. In this study we also 
examined the mechanistic role of RA-V (125 μM) in and colo 320DM cells in the presence of Rapamycin (mTOR inhibitor) 
and chloroquine (autophagy inhibitor) using MDC and AO staining methods. 
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Colon cancer is the major cause of the malignancy in 
the gastrointestinal tract and is the world's third-
largest cause of death
1
. Peptides are recognized for 
their potential to effect anatomical and biochemical 
role of life, through metabolism and reproduction, or 
during the cell- cell communication upon interaction 
with receptors
2
. They are able to inhibit to specific 
destination in vivo without significantly affecting the 
immune system as their equivalents in endogenous 
proteins. In recent decades, they have been the focus 
of an escalated number of studies as they have a wide 
complexity of their component building blocks and 
their decreased toxicity render them attractive 
therapeutic opportunities in diverse fields of science 
and technology. Peptides have also been considered 
as bad drug molecules for different reasons in the 
past, with their rapid metabolism and degradation 
probably the most important disadvantages and the 
reality that many peptides do not normally cross the 
cells as some tiny molecules do
3-6
. Plant cyclic 
peptides have several properties such as target 
selectivity, immunosuppressive activity, good binding 
affinity, anti-inflammatory activity, cytotoxic activity, 
tyrosinase inhibitory activity, target selectivity and 
anti-malarial activity which is used for the 




RA-V is a cyclopeptide isolated from the roots of 
the Chinese medicinal plant Rubia Cordifolia L. of 
the family Rubiaceae. In the Yunnan region of China, 
this plant is used as an anti-cancer herb as it shows 




Autophagy is a self-degradation process of 
unnecessary, injured and aged organelles and proteins 
in the cell, which is followed by recovering of 
degraded products. During invasion and progression, 
cancer cells require ample amount of energy and 
oxygen for maintaining their rapid growth and 
differentiation. Autophagy is the key regulator for 
cellular homeostasis, which has a cytoprotective role 
and is linked to the survival of the cells
10,11
. 
Apoptosis is programmed cell death, which is 
characterized by membrane blebbing, chromosome 
condensation and nuclear fragmentation. There are 
two signalling pathways which regulates the apoptosis 
such as intrinsic pathway and extrinsic pathway. The 
cell undergoes apoptosis in the intrinsic way, as the 
cell experiences stress. In extrinsic pathway, the cell 
undergoes apoptosis because it gets signals from the 








commencer caspase in the intrinsic pathway and 
Caspase-8 is the death receptor mediated initiator 
caspase in the extrinsic pathway
12
. 
Autophagy has been reported to be closely associated 
with apoptosis: (i) autophagy is one of the upstream 
processes required for apoptosis, and inhibition of 
autophagy can effectively inhibit apoptosis  
(ii) autophagy can reduce the rate of apoptosis via 
inhibition of apoptosis (iii) autophagy and apoptosis can 
synergistically promote cell death
13-16
. 
Mammalian target of rapamycin (mTOR) is a vital 
signalling pathway involved in many cellular 
processes. It regulates many intracellular signalling 
molecules to provide energy resources to the cell. The 
involvement of mTOR signalling in Colo rectal 
cancer (CRC) is well known. Similarly, the inhibition 
of mTOR signalling leads to the inhibition of CRC 
cell growth in vitro and adenoma formation in vivo
17
. 
The present study, aims to find the efficacy of RA-V 
cyclopeptide as an autophagy inhibitor to enhance 
apoptosis in Colo 320DM cancer cell lines. 
 
Material and Methods 
 
Materials and Reagents 
RA-V, Roswell Park Memorial Institute 
medium1640 (RPMI-1640), 50X Penicillin and 
Streptomycin Antibiotic, Fetal bovine serum (FBS). 
Monodansylcadaverine (MDC), Rapamycin (RAPA) 
and Chloroquine was purchased from Santa-Cruz. 
Acridine Orange was purchased from SRL. Annexin-
V FITC kit was purchased from Bio-vision. 
 
Cell Culture 
COLO 320DM cells were obtained from NCCS, 
PUNE and cultured at room temperature (37°C) in an 
atmosphere having 5% CO2. Cells were maintained 
with RPMI 1640 media with 5% fetal bovine serum 
(FBS) and 1% antibiotic (penicillin and streptomycin 
cocktail). 
 
Cell Viability (Sulforhodamine B) Assay 
Cell viability assay was performed using 
Sulforhodamine B (SRB) assay kit from Himedia. 
COLO 320DM cells were grown in 96- well plates 
with a density of 1  10
5
 cells/well and incubated for 
24 h. After the treatment of RA-V, the cells were 
fixed with the fixation solution.  After washing four 
times with the washing solution, sulforhodamine dye 
was added to each well and stained for 30 min. Then 
washed four times with the washing solution and 
stained cells were dissolved in the solubilization 
solution. The absorbance was measured at 565 nm 





DAPI staining was performed to determine the 
morphological changes of COLO 320DM cells. The 
cells were seeded at a density of 1  10
5
 cells/well. 
COLO 320DM cells were grown on cover slips in  
6-well plates and incubated for 24 and 48h. COLO 
320DM cells were treated with 100 μM and 125 μM of 
RA-V for 24 and 48 h. The cells were washed with 
PBS after incubation and fixed by acetone/methanol 
(1:1) at room temperature (37C) for 10 min. DAPI 
staining was done for 10 min and washed with PBS. 





Annexin-PI staining assay 
Annexin-PI staining was performed to examine the 
effect of cellular apoptosis in COLO 320DM cells 
which were seeded in 6-well plates and grown for  
24 h. The cells were treated with 100 μM and 125 μM 
of RA-V with and without Rapamycin (1 μM), also 
with and without Chloroquine at the concentration of 
25 μM for 24 and 48 h. Doxorubicin was used as a 
Positive control. After the treatment, the cells were 
centrifuged at 1200 rpm for 10 min at room 
temperature. The pellet was washed with PBS and 
centrifuged again. Pellet was dissolved in 500 μL of 
binding buffer and 5 μL of Annexin-V and PI were 





Staining of autophagic vacuoles by Monodansylcadaverine 
(MDC) 
Monodansylcadaverine staining was performed to 
determine the formation of autophagic vacuoles. 
COLO 320DM cells were grown on cover-slips with 
6 well plates after the treatment with RA-V (100 μM, 
125 μM), Rapamycin (1 μM) and Chloroquine  
(25 μM). For MDC staining, cells were exposed to 
MDC stain (50 μM) in the dark for 15 min. Confocal 





Staining of autolysosomes of Acridine-Orange (AO) 
Acridine-Orange staining was performed to 
determine the formation of autolysosomes. COLO 
320DM cells were grown on cover slips in 6-well 
plates after the treatment with RA-V (100 μM,  
125 μM), Rapamycin (1 μM) and Chloroquine  
(25 μM). For AO staining, cells are exposed to AO 




stain (100 μM) for 15 min. Confocal microscopy 






Statistical analysis was carried out using Graph-pad 
Prism 6 software. The data were analysed using One-
way Anova. Cases with P< 0.0001 were considered to 
be significant. 
 
Results and Discussion 
 
Cell Viability Assay 
Cell viability was evaluated by Sulforhodamine B 
Assay in COLO 320DM cells. RA-V inhibited growth 
of COLO 320DM cells in a time and dosage 
dependent manner (Fig. 1A & B). Increased growth 
inhibition of COLO 320DM cells was found at the 
maximum concentration of 125 μM RA-V 
cyclopeptide as compared to the control. 
 
RA-V induces apoptosis in COLO 320DM cells 
 
DAPI Staining method 
Using DAPI staining, nuclear morphological 
changes of COLO 320DM cells treated with the 
concentrations of 100 μM and 125 μM of RA-V 
cyclopeptide were analysed and photographed with 
fluorescence microscopy. RA-V treated cells at  
125 μM, led to a substantial increase in the number of 
apoptotic cells than 100μM concentration of the 
cyclopeptide which is inferred by fragmented nuclei 
and condensed chromatin which appeared as bright 
blue fluorescence (Fig. 2A-D). DAPI staining of 
(control) untreated cells depicted the absence of 
chromatin condensation and nucleus shrinkage which 
indicated the absence of apoptosis in these untreated 
cells (Control) for 24 and 48 h. Similar results were 
obtained on NSCLC cells treated with  
A. macrocephala which led to an increase in the 





Annexin-PI Staining method 
Annexin-V- PI staining was used to examine the 
effect of RA-V on the cellular apoptosis of COLO 
320DM cells to determine the percentage of apoptotic 
cells. Our results indicated that in untreated cells, 
(Fig. 3A-H), the percentage of the non-apoptotic cells 
was 99.23% and 98.82% which were found to be 
viable for 24 h and 48 h. RA-V treated COLO 320DM 
cells at 100 μM showed that there was an increase in 
the late apoptotic cells of about 7.68% and 9.26%  
as compared to that of positive control, for 24 and  
48 h. RA-V treated COLO 320DM cells at 125 μM 
showed an increase in the late apoptotic cells which 
was about 18.28% and 20.28% as compared to the 
positive control for 24 and 48 h, respectively. 
Rapamycin has been shown to be immunosuppressive 
and an essential signal mediator for PI3 kinase
24
. The 
Rapamycin target (TOR) in yeast and animal cells has 
also been established
25
. In RA-V treated COLO 
320DM cells along with Rapamycin (a mTOR 
inhibitor) at 100 μM, the percentage of dead cells  
for 100 μM was found to be 5.67% and 6.65% for  
24 and 48 h. In RA-V treated cells with Rapamycin at 
125 μM, the percentage of dead cells was found to be 
6.67% and 8.71% for 24 and 48 h, respectively. The 
results indicated that RA-V inhibited protective 
autophagy and also attenuated the activity of 
Rapamycin, a mTOR inhibitor, thereby promoting 
apoptosis of COLO 320DM cells.  
Chloroquine (CQ) mainly inhibits autophagy by 
impairing autophagosome fusion with lysosomes
26,27
. 
Chloroquine is a poor hydrophobic base that diffuses 
through the cell lysosomes, where the cell becomes 
protonated and resulting in an increase in the pH of 
the lysosome.It serves as lysosomotropic agent in 
addition to its anti-cancer effects
28
. This chloroquine 
filled lysosomes are no longer capable of fusing 
autophagosomes, hence, blocking autophagy in the 
 
 
Fig. 1 — Dose dependent inhibition of RA-V on the growth of 
COLO 320DM cells (A) 24 h; and (B) 48 h. The data are 
presented as mean ± SEM (****P< 0.0001, vs Control) 




late stage. In RA-V treated COLO 320DM cells along 
with Chloroquine (an Autophagy inhibitor) at 100 
μM, the percentage of the dead cells for 100 μM was 
found to be 76.49% and 79.39% for 24 and 48 h. In 
RA-V treated COLO 320DM cells with Chloroquine 
at 125 μM, the percentage of the dead cells was found 
to be 80.01% and 88.07% for 24 and 48 h, 
respectively. These results indicated that Chloroquine 
inhibited autophagy and contributes to enhanced 
apoptosis of COLO 320DM cells. 
 
RA-V suppresses autophagy 
The aggregation of autophagic vesicles and 
autolysosome formation are two autophagy markers 
that could be stained by monodansylcadaverine 
(MDC) and acridineorange (AO), respectively. RA-V 
treatment of 125 μM resulted in a significant 
concentration-dependent reduction of autophagic 
vesicles stained with MDC. The mTOR signaling 
pathway was blocked with a special mTOR inhibitor 
rapamycin (RAPA) to elucidate the role of mTOR 
activation in RA-V-inhibited protective autophagy. 
RA-V treatment at the concentration of 125 μM in the 
presence of RAPA showed increased number of 
autophagic vesicles stained with MDC and AO than 
100 μM of the cyclopeptide relative to RA-V-treated 
(125 μM) cells alone (Fig. 4A-D). 
Similar results have been obtained from bright-red 
autolysosomes stained with AO. Reduction in the 
number of autophagosomes may either be related to 
an impaired autophagy or to an unnecessary 
deterioration
29
. Autophagy was studied in the vicinity 
of an inhibitor of autophagy, chloroquine (CQ), which 
prevents lysosome acidification and blocks 
downstream of autophagy. As shown in (Fig. 5A-D), 
combined treatment of RA-V with Chloroquine (CQ) 
inhibited a significant increase of autophagosome 
compared with RA-V treatment alone. 
This research is primarily concerned with the anti-
cancerous effects of RA-V on human colon cancer 
cells, which could provide a basis for drug 
development and colon cancer treatment. TAK1 
inhibition of RA-V prevents protective autophagy 
with TAK2/AMPK/ mTOR and TAK1/P70S6K 
pathways in non-small-cell lung carcinoma (NSCLCs) 
cell -lines that are Kras-dependent
30
. The cyclopeptide 
RA-V, isolated from Rubia Cordifolia L. exhibits 
strong anti-inflammatory and anti-cancer properties in 
a variety of celltypes
31,32
. 
In investigating the effect of this cyclopeptide on 
colon cancer cells, RA-V has been found to induce 
apoptosis in colon cancer cells. Throughout growth and 
aging, natural apoptosis happens as a homeostatic 
process in order to maintain tissue cell populations. 
Autophagy is a retained catabolic technique requiring 
cellular homeostasis and is important under stressful 
conditions for preserving normal cell physiology
33
. It is 
responsible for combating carcinogenic, contagious, 
degenerative and deleterious agents in the preservation 
of the homeostasis of body and control healthy life 
processes
34
. Autophagy could be a selective or non-
selective lysosomal degrading mechanism, and is 




Apoptosis-inducing mechanism, along with chemo 
resistance, tumor growth and metastasis are 
recognized to play an important role in cancer 
pathogenesis
37
. The anti-tumor activity is partly due to 
the initiation of apoptosis. The main anti-cancer 
mechanism of chemotherapy is commonly considered 
to be apoptosis and may be activated by various tumor 
stimulation
38
Many cancer therapy strategies suppress 
tumors by inducing the apoptosis of cancer cell
39
. 
Autophagy was proposed as a tumor suppressing 
method that might reverse or postpone 
tumorigenesis
40,41
. Autophagy is a mechanism of cell 
death through which cytoplasmic organelles and 
proteins are cloistered in vacuoles and carried to 
lysosomes for recycling and degradation
42
. Autophagy  
 
 
Fig. 2 —Photomicrographs of Nuclear staining using DAPI  
of human Colo 320DM cells treated with RA-V for 24 and  
48 h. (A) Control- untreated cells; (B) 125 μM RA-V for 24 h;  
(C) Control- untreated cells; and (D) 125 μM RA-V for 48 h. 
(Arrows indicate cell shrinkage, nuclear fragmentation, and 
margination of the nucleus, all associated with the apoptotic mode 
of cell death) 







Fig. 3 — Annexin V -PI staining of COLO 320DM cells for 24 h (I) and 48 h (II): (A) Control- untreated cells; (B) Positive control; (C) 
100 μM RA-V; (D) 125 μM  RA-V; (E) 100 μM RA-V with inhibitor-1 μM Rapamycin; (F) 125 μM RA-V with inhibitor- 1 μM 
Rapamycin; (G) 100 μM RA-V with inhibitor-25 μM Chloroquine; and (H) 125 μM RA-V with inhibitor-25 μM Chloroquine 
 
is not necessarily pro-death, but can proceed under 
cellular stress conditions, comprising that inhibited by 
chemotherapy or nutrient deprivation
43
. 
RA-V showed cytotoxicity activity in the COLO 
320DM cells. The maximum cytotoxicity was found at 
100 μM and 125 μM. The results showed that RA-V 
inhibits the proliferation of COLO 320DM cells in a 
dosage and time dependent manner (Fig. 1A & B). 
Similar results were found on the cytotoxicity of RA-XII 
on HepG2 cells at the concentrations of 2.5 and 5 μM
44
. 







Fig. 4 — Confocal microscopy analysis of COLO 320DM cells treated with RA-V using MDC staining (I & II) and Acridine Orange (III 
& IV) after 24 h (I & III) and 48 h (II & IV). (A) Control-untreated cells; (B) Inhibitor- 1 μM Rapamycin; (C) 125 μM RA-V; and (D) 




Fig. 5 — Confocal microscopy analysis of COLO 320DM cells treated with RA-V using MDC staining (I & II) and Acridine Orange (III 
& IV) after 24 h (I & III)and 48 h (II & IV). (A) Control-untreated cells; (B) Inhibitor-25 μM Chloroquine; (C) 125 μM RA-V; and (D) 
125 μM RA-V with inhibitor-25 μM Chloroquine 
 
RA-V induced apoptosis in COLO 320DM cells. The 
results showed that nuclear morphological changes were 
represented as chromatin condensation and fragmented 
nuclei (Fig. 2 A-D). Similar results were obtained on the 
inhibition of autophagy and induction of apoptosis 
through the activation of mTOR pathway by RA-XII on 
HepG2 cells
45
. The apoptotic cells in each phase were 
determined (Fig. 3 A - H). Similar results were found on 
the induction of apoptosis on HT-22 cells
45
. 
MDC and AO results indicate that the development 
of autophagic vesicles and autolysosomes by RA-V is 
significantly reduced (Figs. 4 & 5). Also, it suppressed 
protected autophagy and induced apoptosis in the 
COLO 320DM cells.  





The purpose of this study was to elucidate the 
autophagy inhibitory mechanisms underlying RA-V 
in COLO 320DM cells which can impart a scope for 
the innovation of drugs and treatment of colon cancer. 
RA-V substantially decreased the growth of COLO 
320DM cells in a dosage and time- dependent 
manner. The determination of probable mechanism of 
RA-V to induce apoptosis was observed by DAPI 
staining and Annexin-PI staining of COLO 320DM 
cells. In DAPI staining, nuclear morphological 
changes were observed which exhibited as bright blue 
fluorescence. Annexin- PI staining of COLO 320DM 
cells differentiated between the live cells, early 
apoptotic cells, late apoptotic cells and dead cells. 
RA-V also suppresses autophagy and has been 
identified as a powerful autophagy inhibitor. The 
staining results of Monodansylcadaverine and 
Acridine- Orange specified that the autophagic 
vesicles and autolysosomes were significantly 
reduced by RA-V. The experimental findings 
obtained in this study suggest that RA-V can be 
developed as an autophagy blocker for effective 
treatment of colon cancer. 
 
Conflict of interest 
The authors declare no conflict of interest. 
 
References 
1 Granados-Romero JJ, Valderrama-Treviño AI, Contreras-Flores EH, 
Barrera-Mera B, Herrera Enríquez M, Uriarte-Ruíz K,  
Ceballos-Villalba JC, Estrada-Mata AG, Alvarado Rodríguez C 
& Arauz-Peña G, Colorectal cancer: a review. Int J Res Med,  
5 (2017) 4667. 
2 Lau JL & Dunn MK, Therapeutic peptides: Historical 
perspectives, current development trends, and future 
directions. Bioorg Med Chem, 26 (2018) 2700. 
3 Zhong B, Zhang C, Guo S & Zhang C, Rational design of 
cyclic peptides to disrupt TGF-Β/SMAD7 signaling in 
heterotopic ossification. J Mol Graph Model, 72 (2017) 25. 
4 Hicks RP, Antibacterial and anticancer activity of a series of 
novel peptides incorporating cyclic tetra-substituted Cα 
amino acids. Bioorg Med Chem, 24 (2016) 4056. 
5 Bastos M, Silva T, Teixeira V, Nazmi K, Bolscher JG, 
Funari SS & Uhríková, Lactoferrin-derived antimicrobial 
peptide induces a micellar cubic phase in a model membrane 
system. Biophys J, 101 (2011) 20. 
6 Lovering F, Escape from Flatland 2: complexity and 
promiscuity. J Med Chem, 4 (2015) 515.  
7 Dahiya R & Kaur K, Synthetic and biological studies on 
natural cyclic heptapeptide. Segetalin E. Arch Pharmacal 
Res, 30 (2007) 1380. 
8 Fang XY, Chen W, Fan JT, Song R, Wang L, Gu YH,  
Zeng GZ, Shen Y, Wu XF, Tan NH, & Xu Q, Plant 
cyclopeptide RA-V kills human breast cancer cells by 
inducing mitochondria-mediated apoptosis through blocking 
PDK1–AKT interaction. Toxicol Appl Pharmacol, 267 
(2013) 95. 
9 Wang Z, Zhao SM, Chen XQ, Zeng GZ & Tan NH, 
Rubipodanin A, the first natural n-desmonomethylrubiaceae-
type cyclopeptide from Rubia podantha, indicating an 
important role of the 9-methyl group in the conformation and 
bioactivity. PLoS One, 10 (2015) 1. 
10 Yang YP, Hu LF, Zheng HF, Mao CJ Hu WD, Xiong KP, 
Wang F & Liu CF, Application and interpretation of current 
autophagy inhibitors and activators. Acta Pharmacol Sin, 34 
(2013) 625. 
11 Marino G, Niso-Santano M, Baehrecke EH & Kroemer G, 
Self-consumption: the interplay of autophagy and apoptosis. 
Nat Rev Mol Cell Biol, 15 (2014) 81. 
12 Lee MS, Overview of the Minireviews on Autophagy. Mol 
Cells, 41 (2018) 1. 
13 Liu X, Sun K, Wang H & Dai Y, Knockdown of 
retinoblastoma protein may sensitize glioma cells to cisplatin 
through inhibition of autophagy. Neurosci Lett, 620  
(2016) 137. 
14 Li J, Gui Y, Ren J, Liu X, Feng Y, Zeng Z, He W, Yang J & 
Dai C, Metformin protects against cisplatin-induced tubular 
cell apoptosis and acute kidney injury via AMPK α-regulated 
autophagy induction. Sci Rep, 6 (2016) 1. 
15 Lee K, Hong S, Seong GJ & Kim CY, Cigarette smoke 
extract causes injury in primary retinal ganglion cells via 
apoptosis and autophagy. Curr Eye Res, 41 (2016) 1. 
16 Chen X, Tan M, Xie Z, Feng B, Zhao Z, Yang K, Hu C,  
Liao N, Wang T, Chen D & Xie F, Inhibiting ROS-STAT3-
dependent autophagy enhanced capsaicin–induced apoptosis 
in human hepatocellular carcinoma cells. Free Radic Res, 50 
(2016) 744. 
17 Wani ZA, Guru SK, Rao AS, Sharma S, Mahajan G, Behl A, 
Kumar A, Sharma PR, Kamal A, Bhushan S & Mondhe DM, 
A novel quinazolinone chalcone derivative induces 
mitochondrial dependent apoptosis and inhibits 
PI3K/Akt/mTOR signaling pathway in human colon cancer 
HCT-116 cells. Food Chem Toxicol, 87 (2016) 1. 
18 Soysa P, Jayarthne P & Ranathunga I, Water extract of 
Semecarpus parvifolia Thw. leaves inhibits cell proliferation 
and induces apoptosis on HEp-2 cells. BMC Complement 
Altern Med, 18 (2018) 1. 
19 Sunitha M, Chacko 1, Kottayath G, Nevin R, 
Dhanyakrishnan B & Kumar P, Protective effect of  
p-coumaric acid against doxorubicin induced toxicity in 
H9c2 cardiomyoblast cell lines. Toxicol Rep, 2 (2015) 1213. 
20 Zhang X, Mukerji R, Samadi AK & Cohen MS, Down-
regulation of estrogen receptor-alpha and rearranged during 
transfection tyrosine kinase is associated with withaferin a-
induced apoptosis in MCF-7 breast cancer cells. BMC 
Complement Altern Med, 11 (2011) 84. 
21 Chen X, Zhang L, Ding S, Lei Q & Fang W, Cisplatin 
combination drugs induce autophagy in HeLa cells and 
interact with HSA via electrostatic binding affinity. RSC Adv, 
7 (2017) 22270. 
22 Klimaszewska-Wisniewska A, Halas-Wisniewska M, 
Tadrowski T, Gagat M, Grzanka D & Grzanka A, Paclitaxel 
and the dietary flavonoid fisetin: a synergistic combination 
that induces mitotic catastrophe and autophagic cell death in 
A549 non-small cell lung cancer cells. Cancer Cell Int, 16 
(2016) 10. 




23 Liu H, Zhu Y, Zhang T, Zhao Z, Zhao Y, Cheng P, Li H, 
Gao H & Su X. Anti-tumor effects of atractylenolide I 
isolated from Atractylodes macrocephala in human lung 
carcinoma cell lines. Molecules, 18 (2013) 13357. 
24 Chung J, Kuo CJ, Crabtree GR & Blenis J, Rapamycin-
FKBP specifically blocks growth-dependent activation of 
and signaling by the 70 kD S6 protein kinases. Cell, 69 
(1992) 1227. 
25 Laplante M & Sabatini DM, mTOR signaling in growth 
control and disease. Cell, 149 (2012) 274. 
26 Solomon VR & Lee H, Chloroquine and its analogs: a new 
promise of an old drug for effective and safe cancer 
therapies. Eur J Pharmacol, 625 (2009) 220. 
27 Ramirez JAZ, Romagnoli GG, Falasco BF, Gorgulho CM, 
Fogolin CS, Dos Santos DC, Junior JPA, Lotze MT, 
Ureshino RP & Kaneno R, Blocking drug-induced autophagy 
with chloroquine in HCT-116 colon cancer cells enhances 
DC maturation and T cell responses induced by tumor cell 
lysate. Int Immunopharmacol, 84 (2020) 106495. 
28 Sasaki K, Tsuno NH, Sunami E, Tsurita G, Kawai K, Okaji Y, 
Nishikawa T, Shuno Y, Hongo K, Hiyoshi M & Kaneko M. 
Chloroquine potentiates the anti-cancer effect of 5-
fluorouracil on colon cancer cells. BMC cancer, 10 (2010):1. 
29 Katz SJ & Russell AS, Re-evaluation of antimalarials in  
treating rheumatic diseases: re-appreciation and insights  
into new mechanisms of action. Curr Opin Rheumatol, 23 
(2011) 278. 
30 Lee YA, Noon LA, Akat KM, Ybanez MD, Lee TF,  
Berres ML, Fujiwara N, Goossens N, Chou HI, Parvin-Nejad 
FP & Khambu B, Autophagy is a gatekeeper of hepatic 
differentiation and carcinogenesis by controlling the 
degradation of Yap. Nat Commun, 9 (2018) 1. 
31 Yang J, Yang T, Yan W, Li D, Wang F, Wang Z, Guo Y,  
Bai P, Tan N & Chen L, TAK1 inhibition by natural 
cyclopeptide RA-V promotes apoptosis and inhibits 
protective autophagy in Kras-dependent non-small-cell lung 
carcinoma cells. RSC Adv, 8 (2018) 23451. 
32 De Veer, Simon J, Meng-Wei Kan & David JC, Cyclotides: 
from structure to function. Chem Rev, 119 (2019) 12375. 
33 Fan J, Su J, Peng YM, Li Y, Li J, Zhou YB, Zeng GZ, Yan H 
& Tan NH, Rubiyunnanins C–H, cytotoxic cyclic 
hexapeptides from Rubiayunnanensis inhibiting nitric oxide 
production and NF-κB activation. Bioorg Med Chem, 18 
(2010) 8226. 
34 Cooper KF, Till death do us part: the marriage of autophagy 
and apoptosis. Oxidative medicine and cellular longevity. 
Hindawi, 2018 (2018) 1. 
35 Lee YA, Noon LA, Akat KM, Ybanez MD, Lee TF,  
Berres ML, Fujiwara N, Goossens N, Chou HI, Parvin-Nejad FP 
& Khambu B, Autophagy is a gatekeeper of hepatic 
differentiation and carcinogenesis by controlling the 
degradation of Yap. Nat Commun, 9 (2018) 1. 
36 Füllgrabe J, Ghislat G, Cho DH & Rubinsztein DC, 
Transcriptional regulation of mammalian autophagy at a 
glance. J Cell Sci, 129 (2016) 3059. 
37 Yun CW & Lee SH, The roles of autophagy in cancer. Int  
J Mol Sci, 19 (2018) 3466. 
38 Swadesh S, Amrita P, Anirban C & Santanu P, A novel 
compound β-sitosterol-3-O-β-D-glucoside isolated from 
Azadirachta indica effectively induces apoptosis in leukemic 
cells by targeting G0/G1 populations. Indian J Biochem 
Biophys, 57 (2020) 51. 
39 Mostafa NT & Ebrahim V, Cytotoxic, antimicrobial and 
DNA breaking activity of Salgam. Indian J Biochem 
Biophys, 56 (2019) 169. 
40 Liu JJ, Lin M, Yu JY, Liu B & Bao JK Targeting apoptotic 
and autophagic pathways for cancer therapeutics. Cancer 
Lett, (2011) 105. 
41 Xu D, Lao Y, Xu N, Hu H, Fu W, Tan H, Gu Y, Song Z, Cao P 
& Xu H, Identification and characterization of anticancer 
compounds targeting apoptosis and autophagy from Chinese 
native Garcinia species. Planta Med, 81 (2015) 79. 
42 Maiuri MC, Zalckvar E, Kimchi A & Kroemer G, Self-eating 
and self-killing: crosstalk between autophagy and apoptosis. 
Nat Rev Mol Cell Biol, 8 (2007) 741. 
43 Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T,  
Atomi Y, Ueno T, Ochiai A &Esumi H, Autophagy is 
activated in colorectal cancer cells and contributes to the 
tolerance to nutrient deprivation. Cancer Res, 67 (2007) 9677. 
44 Song L, Wang Z, Wang Y, Guo D, Yang J, Chen L & Tan N, 
Natural cyclopeptide RA-XII, a new autophagy inhibitor, 
suppresses protective autophagy for enhancing apoptosis 
through AMPK/mTOR/P70S6K pathways in HepG2 cells. 
Molecules, 22 (2017) 1934. 
45 Ramadoss DP & Sivalingam N, Vanillin extracted from Proso 
and Barnyard millets induce apoptotic cell death in HT-29 
human colon cancer cell line. Nutr Cancer, 1 (2019) 1. 
 
